Insufficient scRNA-seq data for expression of DHFR2 at single-cell level.
Insufficient scRNA-seq data for expression of DHFR2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 449.33 | 245 / 245 | 100% | 13.17 | 501 / 502 |
brain | 100% | 524.46 | 2631 / 2642 | 100% | 15.49 | 704 / 705 |
breast | 100% | 485.27 | 459 / 459 | 99% | 11.67 | 1111 / 1118 |
thymus | 100% | 480.41 | 653 / 653 | 99% | 10.36 | 600 / 605 |
pancreas | 99% | 335.58 | 324 / 328 | 99% | 7.19 | 176 / 178 |
esophagus | 99% | 431.74 | 1430 / 1445 | 98% | 6.99 | 180 / 183 |
bladder | 100% | 519.38 | 21 / 21 | 96% | 6.44 | 485 / 504 |
skin | 99% | 410.84 | 1799 / 1809 | 96% | 9.61 | 455 / 472 |
kidney | 99% | 337.38 | 88 / 89 | 97% | 8.30 | 872 / 901 |
uterus | 100% | 787.95 | 170 / 170 | 95% | 7.43 | 438 / 459 |
stomach | 99% | 374.77 | 355 / 359 | 97% | 6.30 | 276 / 286 |
ovary | 100% | 679.57 | 180 / 180 | 95% | 5.36 | 410 / 430 |
intestine | 100% | 531.76 | 963 / 966 | 95% | 6.33 | 503 / 527 |
adrenal gland | 98% | 562.99 | 254 / 258 | 96% | 7.09 | 220 / 230 |
lung | 93% | 344.02 | 536 / 578 | 98% | 8.05 | 1134 / 1155 |
liver | 100% | 293.48 | 225 / 226 | 87% | 4.54 | 352 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.21 | 29 / 29 |
spleen | 100% | 403.71 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.88 | 1 / 1 |
blood vessel | 100% | 501.71 | 1333 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 436.49 | 1200 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 8.87 | 44 / 45 |
heart | 90% | 233.84 | 778 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 83% | 4.21 | 66 / 80 |
muscle | 74% | 111.72 | 595 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 57% | 179.12 | 530 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046105 | Biological process | thymidine biosynthetic process |
GO_0046655 | Biological process | folic acid metabolic process |
GO_0006730 | Biological process | one-carbon metabolic process |
GO_0046653 | Biological process | tetrahydrofolate metabolic process |
GO_0046654 | Biological process | tetrahydrofolate biosynthetic process |
GO_0046452 | Biological process | dihydrofolate metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0033560 | Molecular function | folate reductase activity |
GO_0050661 | Molecular function | NADP binding |
GO_0004146 | Molecular function | dihydrofolate reductase activity |
GO_0003729 | Molecular function | mRNA binding |
Gene name | DHFR2 |
Protein name | dihydrofolate reductase (EC 1.5.1.3) Dihydrofolate reductase 2, mitochondrial (Dihydrofolate reductase, mitochondrial) (EC 1.5.1.3) (Dihydrofolate reductase-like protein 1) |
Synonyms | DHFRP4 DHFRL1 |
Description | FUNCTION: Key enzyme in folate metabolism. Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. Required to prevent uracil accumulation in mtDNA. Binds its own mRNA and that of DHFR. . |
Accessions | ENST00000619045.1 ENST00000461173.5 ENST00000314636.3 Q86XF0 C9JJ68 ENST00000496983.1 ENST00000394221.3 |